article · Egyptian Journal of Cancer and Biomedical Research.
Background: Brown algae are known for synthesizing bioac-tive compounds with anti-inflammatory properties, which have shown potential in addressing inflammation-related disorders. Osteoarthritis (OA), a joint disease characterized by significant inflammation, negatively impacts overall health and quality of life. Aim:This study aimed to evaluate the therapeutic potential of algi-nate extracted from the brown algae Cystoseira indica in miti-gating OA using a rat model. Materials & Methods: OA was induced in rats through intra-articular administration of mono-sodium iodoacetate (MIA). The experimental design included a control group, an MIA-induced OA group, and an alginate-treated group (MIA + alginate). Samples were collected at in-tervals of 2, 4, 6, and 10 weeks to assess pro-inflammatory cy-tokine levels, biochemical markers, and histopathological changes in knee cartilage. ResultsOA induction led to a significant increase in pro-inflammatory and oxidative stress markers, including malondialdehyde (MDA), interleukin 1-beta (IL1β), tumor necrosis factor-alpha (TNF-α), beta-glucuronidase (β-G), acid phosphatase (ACP), and aggrecanase 1, alongside a marked reduction in glutathi-one (GSH) levels. Alginate treatment significantly mitigated OA progression, as evidenced by reduced levels of MDA, IL1β, TNF-α, β-G, ADAMTS4, and matrix metalloproteinase-3 (MMP-3), coupled with increased GSH levels and improved cartilage recovery and regeneration. ConclusionAlginate from C. indica demonstrates significant potential in mitigating OA through its anti-inflammatory effects, highlight-ing its promise as a therapeutic agent for inflammation-related joint disorders.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/jcbr.2025.353492.1382
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.